Efficacy and safety of DPP-1 inhibitors in bronchiectasis: a GRADE-assessed meta-analysis of randomized controlled trials

Abstract Background Bronchiectasis is a chronic inflammatory airway disease characterized by frequent exacerbations and neutrophilic inflammation. Dipeptidyl peptidase-1 (DPP-1) inhibitors block neutrophil serine protease activation and represent a promising therapeutic approach. This meta-analysis...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Ahmed Emara, Ameer Awashra, Mohamed Ellebedy, Omar F. Abbas, Ahmed Diaa, Mohamed S. Elgendy, Mohamed Emara, Abdalhakim Shubietah, Abdul Muhsen Z. Abdeen, Fadi Safi
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2025-11-01
Saila:	Respiratory Research
Gaiak:	Bronchiectasis DPP-1 inhibitor Brensocatib Exacerbation Neutrophil elastase Meta-analysis
Sarrera elektronikoa:	https://doi.org/10.1186/s12931-025-03407-2
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!